Health & Aging Brain Study: Health Disparities TAU Project
NCT04324541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2024-05-17
Summary
By doing this study we are trying to learn more about brain aging in Mexican Americans.
Participants will be asked to complete a screening visit to determine if it is safe to undergo a PET scan.
If eligible, participants will undergo a medical procedure that takes a picture of their brain. This procedure is called a PET scan of the brain.
Conditions
- Brain Aging in Mexican Americans
Interventions
- DIAGNOSTIC_TEST
-
PET scan of the brain with Flortaucipir
PET scan of the brain with non FDA approved Radio tracer.
Sponsors & Collaborators
-
Sid E. O'Bryant
lead OTHER
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-23
- Primary Completion
- 2019-10-17
- Completion
- 2021-04-20
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases
NCT06731842 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Imaging Tau in Alzheimer's Disease and Normal Aging
NCT03373604 ·Status: COMPLETED ·Phase: PHASE2
-
[18F]PI-2620 Phase 3 Histopathological Study
NCT05641688 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
NCT02103894 ·Status: COMPLETED ·Phase: PHASE1
-
F 18 T807 Tau PET Imaging of Alzheimer's Disease
NCT02414347 ·Status: RECRUITING
-
Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
NCT02795780 ·Status: COMPLETED ·Phase: PHASE2
-
Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study
NCT05393388 ·Status: ACTIVE_NOT_RECRUITING
-
Neuroimaging Study
NCT03618186 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
NCT03389100 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
NCT02079766 ·Status: COMPLETED ·Phase: PHASE2
-
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind
NCT03024944 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR
NCT04383808 ·Status: RECRUITING ·Phase: NA
-
Clinical Evaluation of Flortaucipir F 18
NCT02278367 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Test-retest Evaluation of [18F]MNI-958 PET
NCT03545789 ·Status: COMPLETED ·Phase: PHASE1
-
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
NCT05658913 ·Status: RECRUITING
-
Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
NCT02640092 ·Status: COMPLETED ·Phase: PHASE1
-
Flortaucipir PET Imaging in Subjects With FTD
NCT03040713 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein
NCT03071224 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
NCT03080051 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls
NCT03625128 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Tau Imaging in Professional Fighters
NCT02278354 ·Status: COMPLETED ·Phase: PHASE1
-
Tau Imaging of Chronic Traumatic Encephalopathy
NCT02191267 ·Status: COMPLETED ·Phase: PHASE2
-
Assess Fibrin in Brains With AD/ADRD
NCT05336695 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.
NCT03816228 ·Status: WITHDRAWN
-
Tau PET Imaging in the NACC Study Cohort
NCT03189485 ·Status: ACTIVE_NOT_RECRUITING